ইঙ্গিত ও ব্যবহার
Zinforo এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
প্রাপ্তবয়স্ক:
The duration of therapy should be guided by the severity and site of infection and the patient’s clinical and bacteriological progress. Indications Age Range Dosage Infusion Time Duration Acute Bacterial Skin and Skin Structure Infections 18 years and older 600 mg every 12 hours 5 to 60 minutes 5 to 14 days ≥2 years to <18 years (>33 kg) 600 mg every 12 hours 5 to 60 minutes 5 to 14 days ≥2 years to <18 years (≤33kg) 12 mg/kg every 8 hours 5 to 60 minutes 5 to 14 days 2 months to <2 years 8 mg/kg every 8 hours 5 to 60 minutes 5 to 14 days 0 to <2 months 6 mg/kg every 8 hours 30 to 60 minutes 5 to 14 days Community Acquired BacterialPneumonia 18 years and older 600 mg every 12 hours 5 to 60 minutes 5 to 14 days ≥2 years to <18 years (>33 kg) 600 mg every 12 hours 5 to 60 minutes 5 to 14 days ≥2 years to <18 years (≤33kg) 12 mg/kg every 8 hours 5 to 60 minutes 5 to 14 days 2 months to <2 years 8 mg/kg every 8 hours 5 to 60 minutes 5 to 14 days
পার্শ্বপ্রতিক্রিয়া
The common side effects include diarrhea, nausea, vomiting, abdominal pain, headache, dizziness, rash, pruritus, increased transaminases, phlebitis, pyrexia and infusion site reactions (erythema, phlebitis, pain). The uncommon side effects are anemia, leucopenia, thrombocytopenia, hypersensitivity/anaphylaxis, urticaria, Clostridium difficile colitis, prolonged prothrombin time, increased blood creatinine; and rarely eosinophilia.
সতর্কতা ও নিষেধাজ্ঞা
সতর্কতা ও সাবধানতা
Serious hypersensitivity (anaphylactic) reactions have been reported with beta-lactam antibacterial drugs, including Cefamil-5. If a hypersensitivity reaction occurs, discontinue Cefamil-5. Clostridium difficile-associated diarrhea (CDAD) has been reported with nearly all systemic antibacterial agents, including Cefamil-5. Evaluate if diarrhea occurs.Neurological adverse reactions have been reported in patients treated with cephalosporins, including Cefamil-5. If neurological adverse reactions occur, consider discontinuing Cefamil-5 or making appropriate dosage adjustments in patients with renal impairment.If anemia develops during or after therapy, a diagnostic workup for drug-induced hemolytic anemia should be performed and consideration given to discontinuation of Cefamil-5.
নিষেধাজ্ঞা
Hypersensitivity to the active substance or to any of its excipients. Hypersensitivity to the cephalosporin class of antibacterials. Immediate and severe hypersensitivity (e.g., anaphylactic reaction) to any other type of beta-lactam antibacterial agent (e.g., penicillins or carbapenems).